CN102210820A - Chinese medicinal composition for treating leukemia - Google Patents
Chinese medicinal composition for treating leukemia Download PDFInfo
- Publication number
- CN102210820A CN102210820A CN2011101459552A CN201110145955A CN102210820A CN 102210820 A CN102210820 A CN 102210820A CN 2011101459552 A CN2011101459552 A CN 2011101459552A CN 201110145955 A CN201110145955 A CN 201110145955A CN 102210820 A CN102210820 A CN 102210820A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 208000032839 leukemia Diseases 0.000 title abstract description 7
- 241000222336 Ganoderma Species 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 241000005787 Cistanche Species 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 241000282994 Cervidae Species 0.000 claims abstract description 9
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 3
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 33
- 210000000582 semen Anatomy 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 11
- 241000208340 Araliaceae Species 0.000 claims description 9
- 241000190633 Cordyceps Species 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 210000000278 spinal cord Anatomy 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 244000281702 Dioscorea villosa Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241001446509 Psoralea Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241001165494 Rhodiola Species 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 4
- 241000132012 Atractylodes Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 240000005373 Panax quinquefolius Species 0.000 abstract 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 244000169544 Duchesnea indica Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000002624 Mespilus germanica Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 240000001307 Myosotis scorpioides Species 0.000 abstract 1
- 235000014676 Phragmites communis Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241001530126 Scrophularia Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000011453 Vigna umbellata Nutrition 0.000 abstract 1
- 240000001417 Vigna umbellata Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 40
- 210000004369 blood Anatomy 0.000 description 39
- 230000000694 effects Effects 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 238000002156 mixing Methods 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 230000000259 anti-tumor effect Effects 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000003266 anti-allergic effect Effects 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000002633 protecting effect Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010000830 Acute leukaemia Diseases 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 2
- 206010003497 Asphyxia Diseases 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000024207 chronic leukemia Diseases 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010028024 Mouth haemorrhage Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000009613 Oral Hemorrhage Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000001357 hemopoietic progenitor cell Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating leukemia. The Chinese medicinal composition is prepared from Chinese herbal medicines in part by weight: 60 to 150 parts of glossy privet fruit, 20 to 80 parts of Chinese magnoliavine fruit, 60 to 150 parts of reed rhizome, 20 to 80 parts of common selfheal fruit, 20 to 80 parts of cinnamomvine, 20 to 80 parts of malaytea scurfpea fruit, 60 to150 parts of desertliving cistanche, 20 to 80 parts of eucommia bark, 20 to 80 parts of eclipta alba, 20 to 80 parts of mulberry, 20 to 80 parts of white paeony root, 20 to 80 parts of red paeony root, 60 to 150 parts of anemarrhena asphodeloides, 20 to 80 parts of sweet wormwood herb, 20 to 80 parts of dried rehmannia root, 20 to 80 parts of prepared rehmannia root, 20 to 80 parts of fragrant solomonseal rhizome, 100 to 200 parts of Chinese angelica, 20 to 80 parts of astragalus, 5 to 35 parts of licorice root, 20 to 80 parts of honeysuckle flower, 20 to 80 parts of peach seed, 20 to 80 parts of Indian buead, 20 to 80 parts of largehead atractylodes rhizome, 20 to 80 parts of red date, 20 to 80 parts of medlar, 20 to 80 parts of small red beans, 20 to 80 parts of swordlike atractylodes rhizome, 100 to 200 parts of gloss ganoderma, 20 to 80 parts of scrophularia, 20 to 80 parts of rhubarb, 9 to 20 parts of Chinese caterpillar fungus, 50 to 120 parts of ginseng, 60 to 150 parts of American ginseng, 9 to 20 parts of saffron, 20 to 80 parts of bletilla striata, 20 to 80 parts of rhodiola rosea, 20 to 80 parts of notoginseng root, 20 to 80 parts of turtle shell, 20 to 80 parts of India mockstrawberry herb and 300 to 700 parts of deer medulla spinalis.
Description
Technical field
The present invention relates to the leukemic Chinese medicine composition of a kind of treatment, particularly a kind of is the Chinese medicine composition of feedstock production with the Chinese herbal medicine.
Background technology
Leukemia people are commonly called as leukemia, are a kind of very intensive malignant diseases that seriously jeopardizes human health of damage hematopoietic stem cell that destroys.Got this disease, leukaemia's a large amount of hypertrophy in bone marrow and other hemopoietic tissue are gathered, and soak into or destroy other organs and tissue, and normal plasma cell is suppressed.Development speed and natural history according to the leukaemia, leukemia can be divided into acute and chronic two big classes: the cell differentiation of acute leukemia is stuck in the stage early, mostly be germinal cell and early stage juvenile cell, PD is rapid, natural history is several months only, the lift energy that is to say people under the situation of not treating is kept some months, and therefore, the early treatment is particularly important; The cell differentiation of chronic leukemia is stuck in late phase, mostly is ripe juvenile cell and mature cell, and PD is slow, and natural history is the several years.Secondly acute leukemia can be divided into acute lymphoblastic leukemia and acute nonlymphocytic leukemia according to the cell line of mainly getting involved; Chronic leukemia is divided into chronic myelocytic leukemia and chronic lymphocytic leukemia, and in addition, Lymphocytic leukemia thrombocytopenia and aplastic anemia also belong to leukemic category.
Leukemic cause is many by viral factor, the radiation factor, and due to the inherited genetic factorss etc., its cardinal symptom shows as: heating, anemia, subcutaneous hemorrhage, oral hemorrhage, nasal bleeding, liver spleen and lymphadenectasis, breastbone rib tenderness, lymph nodes of body as a whole enlargement in late period can have bleeding.Also do not have effective Therapeutic Method at present, present Therapeutic Method mainly contains radiotherapy, chemotherapy, doctor trained in Western medicine methods such as bone marrow transplant.Though radiotherapy or chemotherapy can be killed the part cancerous cell, patient symptom is temporarily taken a turn for the better or alleviate, when it kills and wounds cancerous cell, injured normal immunocyte leukocyte, damaged the human righteousness, side effect is big, bring insufferable misery to patient, some critical patient is forced to therapy discontinued.Bone marrow transplant earlier intravital cell of patient and immune system, kills with heavy dose of chemicals before bone marrow transplantation, disposes, and then transplants.If the part of the marrow hemopoietic stem cells after the dose of usefulness big (causing drug residue) is transplanted will be killed by remaining medicine.If the dose of usefulness is few, just there is not enough strength that original tumor cell and other cells are all removed totally, cancerous cell is with regard to continued growth, so this bone marrow transplant Therapeutic Method mortality is very high.Numerous medical personnels are studying intensively, and seek the effective ways of treatment, but also effectively do not cure leukemic medicament at present.
Summary of the invention
The problem to be solved in the present invention is: provide a kind of treatment leukemic Chinese medicine composition, screening has heat-clearing and toxic substances removing from Chinese herbal medicine, strengthening vital QI to eliminate pathogenic factors, the kidney tonifying spleen reinforcing, the natural plant of benefiting qi and nourishing blood, the effectively growth of anticancer diffusion makes patient's cancerous cell approaching to normal cell, reaches the purpose of healing.
In order to solve the problems of the technologies described above, the leukemic Chinese medicine composition of treatment of the present invention is made up of the component of following proportioning by weight:
Fructus Ligustri Lucidi 60-150 part, Fructus Schisandrae Chinensis 20-80 part, Rhizoma Phragmitis 60-150 part, Spica Prunellae 20-80 part, Rhizoma Dioscoreae 20-80 part, Fructus Psoraleae 20-80 part, Herba Cistanches 60-150 part, Cortex Eucommiae 20-80 part, Herba Ecliptae 20-80 part, Fructus Mori 20-80 part, Radix Paeoniae Alba 20-80 part, Radix Paeoniae Rubra 20-80 part, Rhizoma Anemarrhenae 60-150 part, Herba Artemisiae Annuae 20-80 part, Radix Rehmanniae 20-80 part, Radix Rehmanniae Preparata 20-80 part, Rhizoma Polygonati Odorati 20-80 part, Radix Angelicae Sinensis 100-200 part, Radix Astragali 20-80 part, Radix Glycyrrhizae 5-35 part, Flos Lonicerae 20-80 part, Semen Persicae 20-80 part, Poria 20-80 part, Rhizoma Atractylodis Macrocephalae 20-80 part, Fructus Jujubae 20-80 part, Fructus Lycii 20-80 part, Semen Ormosiae Hosiei 20-80 part, Rhizoma Atractylodis 20-80 part, Ganoderma 100-200 part, Radix Scrophulariae 20-80 part, Radix Et Rhizoma Rhei 20-80 part, Cordyceps 9-20 part, Radix Ginseng 50-120 part, Radix Panacis Quinquefolii 60-150 part, Stigma Croci 9-20 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-80 part, Radix Rhodiolae 20-80 part, Radix Notoginseng 20-80 part, Carapax Trionycis 20-80 part, Herba Duchesneae Indicae 20-80 part, deer spinal cord 300-700 part.
The leukemic Chinese medicine composition of treatment of the present invention, preferred each component ratio of weight and number is:
Fructus Ligustri Lucidi 80-120 part, Fructus Schisandrae Chinensis 40-60 part, Rhizoma Phragmitis 80-120 part, Spica Prunellae 40-60 part, Rhizoma Dioscoreae 40-60 part, Fructus Psoraleae 40-60 part, Herba Cistanches 80-120 part, Cortex Eucommiae 40-60 part, Herba Ecliptae 40-60 part, Fructus Mori 40-60 part, Radix Paeoniae Alba 40-60 part, Radix Paeoniae Rubra 40-60 part, Rhizoma Anemarrhenae 80-120 part, Herba Artemisiae Annuae 40-60 part, Radix Rehmanniae 40-60 part, Radix Rehmanniae Preparata 40-60 part, Rhizoma Polygonati Odorati 40-60 part, Radix Angelicae Sinensis 130-170 part, Radix Astragali 40-60 part, Radix Glycyrrhizae 10-30 part, Flos Lonicerae 40-60 part, Semen Persicae 40-60 part, Poria 40-60 part, Rhizoma Atractylodis Macrocephalae 40-60 part, Fructus Jujubae 40-60 part, Fructus Lycii 40-60 part, Semen Ormosiae Hosiei 40-60 part, Rhizoma Atractylodis 40-60 part, Ganoderma 130-170 part, Radix Scrophulariae 40-60 part, Radix Et Rhizoma Rhei 40-60 part, Cordyceps 12-18 part, Radix Ginseng 60-100 part, Radix Panacis Quinquefolii 80-120 part, Stigma Croci 12-18 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-60 part, Radix Rhodiolae 40-60 part, Radix Notoginseng 40-60 part, Carapax Trionycis 40-60 part, Herba Duchesneae Indicae 40-60 part, deer spinal cord 400-600 part
The present invention treats leukemic Chinese medicine composition, and optimum each component ratio of weight and number is:
100 parts of Fructus Ligustri Lucidi, 50 parts of Fructus Schisandrae Chinensis, 100 parts of Rhizoma Phragmitiss, 50 parts of Spica Prunellaes, 50 parts of Rhizoma Dioscoreaes, 50 parts of Fructus Psoraleaes, 100 parts of Herba Cistanches, 50 parts of the Cortexs Eucommiae, 50 parts of Herba Ecliptaes, 50 parts of Fructus Mori, 50 parts of Radix Paeoniae Alba, 50 parts of Radix Paeoniae Rubras, 100 parts of the Rhizoma Anemarrhenaes, 50 parts of Herba Artemisiae Annuaes, 50 parts of Radix Rehmanniae, 50 parts of Radix Rehmanniae Preparata, 50 parts of Rhizoma Polygonati Odorati, 150 parts of Radix Angelicae Sinensis, 50 parts of the Radixs Astragali, 20 parts in Radix Glycyrrhizae, 50 parts of Flos Loniceraes, 50 parts in Semen Persicae, 50 parts in Poria, 50 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Fructus Jujubaes, 50 parts of Fructus Lycii, 50 parts of Semen Ormosiae Hosiei, 50 parts of Rhizoma Atractylodis, 150 parts of Ganodermas, 50 parts of Radix Scrophulariae, 50 parts of Radix Et Rhizoma Rhei, 15 parts of Cordyceps, 80 parts of Radix Ginsengs, 100 parts of Radix Panacis Quinquefoliis, 15 parts of Stigma Crocis, 50 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 50 parts of Radix Rhodiolaes, 50 parts of Radix Notoginseng, 50 parts of Carapax Trionycis, 50 parts of Herba Duchesneae Indicaes, 500 parts in deer spinal cord.
Below the effect and the pharmacology of each main component are done concrete analysis:
Fructus Ligustri Lucidi: liver and kidney tonifying; Clearind deficient heat; Make eye bright.Can human body immunity improving power, have antiinflammatory, anticancer, the effect of mutation.
Fructus Schisandrae Chinensis: astringe the lung, nourishing kidney is promoted the production of body fluid, and receives antiperspirant, arresting seminal emission.Fructus Schisandrae Chinensis can promote the synthetic of hepatic glycogen, and carbohydrate metabolism is strengthened, and it is proteinic synthetic to increase hepatocyte again.To lymphocyte DNA is synthetic facilitation is arranged, lymphoblast is generated increase, and promote the spleen immunologic function
Rhizoma Phragmitis: clearing away heat and promoting production of body fluid; Relieve restlessness and prevent vomiting; Diuresis; Rash.Can heat clearing away, blood fat reducing, blood pressure lowering, anticancer Germinatus Phragmitis, be equipped with sweetly lightly be slightly cold, clearing away heat and promoting diuresis, the Fructus Benincasae of detoxifying, promoting the production of body fluid, not only refrigerant tasty and refreshing, and human body had health-care effect preferably.Normal food all has better curative effect to diseases such as hypertension, hyperlipidemia, arteriosclerosis, cancer and edema, cough, nephropathy, edema disease, diabetes, obesity
Spica Prunellae: liver heat removing, eliminating stagnation, diuresis.Has antiinflammatory, antibiotic, anticancer effect.
Rhizoma Dioscoreae: heat clearing away, detoxifcation.Has human body immunity improving power, blood sugar lowering, nourishing effects
Fructus Psoraleae: warming the kidney to activate YANG, improving inspiration by invigorating kidney-QI, antidiarrheal.
Herba Cistanches: kidney-replenishing, benefiting essence-blood, loosening bowel to relieve constipation.Improving immunocompetence.Herba Cistanches polysaccharides all has remarkable influence to the formation and the activity of human lymphocyte, and it can increase proliferation of lymphocytes, thus enhancing body's immunological function.
The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening, antiabortive.There are substantial connection in various trace elements that is rich in the Cortex Eucommiae and human endocrine system, immunologic function system, and lymphocyte is played the short fissional effect of specificity.
Herba Ecliptae: removing heat from blood, hemostasis, the kidney invigorating, tonifying YIN
Fructus Mori: nourishing YIN and benefiting blood; Promote the production of body fluid; Intestine moistening.Raise immunity has moderate to excite LT effect.
Radix Paeoniae Alba: nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Has spasmolytic, hepatoprotective, analgesic activity.
Radix Paeoniae Rubra: blood stasis dispelling, pain relieving, removing heat from blood, detumescence.Have antiplatelet aggregation, antitumor, analgesia protects the liver effects such as blood fat reducing.
The Rhizoma Anemarrhenae: nourishing YIN to lower pathogenic fire, moisturize laxation.Have resisting pathogenic microbes, blood sugar lowering, analgesic, the antineoplastic effect.
Herba Artemisiae Annuae: heat clearing away, expelling summer-heat removes and steams
Radix Rehmanniae: clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting.Radix Rehmanniae has effects such as certain heart tonifying, diuresis, rising blood pressure, blood sugar lowering.The extract of Radix Rehmanniae can promote solidifying of blood.Also have the liver protecting, prevent the effect that hepatic glycogen reduces.And certain Antiradiation injury effect arranged.Multiple fungi growth there is inhibitory action.
Radix Rehmanniae Preparata: nourishing YIN and supplementing blood, beneficial essence is filled out marrow.
Rhizoma Polygonati Odorati: yin nourishing, to moisturize, relieving restlessness is quenched the thirst.Can strengthen the peritoneal macrophage phagocytosis, improve the serum hemolysin antibody horizontal, improve the breeder reaction of splenocyte ConA.
Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.
The Radix Astragali: invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.Can raise immunity, enhancing body anoxia enduring and stress ability promote organism metabolism, improve cardiac function, have blood pressure lowering, protect the liver, blood sugar regulation, anti-mattress and suppress effect such as virus.
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
Flos Lonicerae: heat-clearing and toxic substances removing, wind-heat dissipating.Main pharmacological: the one, antibiotic and antiviral.Promptly staphylococcus aureus, Hemolytic streptococcus, dysentery, typhoid fever, meningococcus, Diplococcus pneumoniae, green pus and influenza virus etc. all there is obvious inhibitory action.The 2nd, the function of enhance immunity is arranged.Flos Lonicerae can promote lymphocyte transformation, strengthens leukocytic phagocytic function.The 3rd, antiinflammatory, analgesic.Flos Lonicerae can promote the release of adrenocortical hormone, and inflammation is had obvious inhibitory action
Semen Persicae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.Has blood stasis dispelling blood, antiinflammatory, anti-allergic effects.
Poria: eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming.Can strengthen the lymphocytic cytotoxic effect of T, promptly strengthen cell immune response, can make the caused by cyclophosphamide leukopenia quicken, increase the cytotoxic effect of macrophage, antibiotic, diuresis, antitumor action.
The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and benefiting QI, the dampness diuretic, hidroschesis, antiabortive.Have blood sugar lowering, anticoagulation, antitumor action, can significantly strengthen the ability of leukocytes phagocytic staphylococcus aureus, significantly promote the hemopoietic progenitor cell of red blood cell line nucleus formation, diuresis, stress.
Fructus Jujubae: invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind, the mitigation property of medicine.Can strengthen body immunity, muscle strength reinforcing, weight increase, the liver protecting, antiallergic, tranquillizing and allaying excitement, anticancer, mutation.
Fructus Lycii: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, blood-enriching tranquillizing, promoting the production of body fluid to quench thirst, nourishing the lung to arrest cough.Has the effect that improves Abwehrkraft des Koepers.
Semen Ormosiae Hosiei: remove pyretic toxicity, dispelling malignant blood, relieving distension is full, diuresis, lactogenesis.Have good loosening bowel to relieve constipation, blood pressure lowering, blood fat reducing, blood sugar regulation, detoxicating and fighting cancer, the effect of prevention calculus
Rhizoma Atractylodis: spleen invigorating, dampness, resolving depression, ward off dirty, expelling cold and relieving exterior syndrome.Has calmness, hypoglycemic activity.
Ganoderma: strengthening the body resistance, raise immunity improves Abwehrkraft des Koepers.Have antitumor, protecting liver and detoxication, defying age, neurasthenia, treatment hypertension, treatment diabetes, treatment chronic bronchitis, effects such as bronchial asthma, antiallergic, beauty treatment.
Radix Scrophulariae: removing heat from blood YIN nourishing, eliminating fire and detoxication, fever excessive thirst, spontaneous sweating, constipation, haematemesis nose bleeding, pharyngolaryngitis, pulmonary tuberculosis.
Radix Et Rhizoma Rhei: heat and toxic materials clearing away, clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.Hemostasis arranged, protect the liver, effect such as blood pressure lowering, reduction serum cholesterol.
Cordyceps: kidney-reinforcing Yang-strengthening, tonifying the lung is relievingd asthma, hemostasis and phlegm.Have gonadotropic Effect, regulate body's immunity, relieving asthma, protect renal function, strengthen effects such as hemopoietic function, slow down aging.Cordyceps also has protecting the liver, suppresses organ transplant rejection, suppresses effects such as lupus erythematosus, blood sugar lowering, antitumor.
Radix Ginseng: strongly invigorating primordial QI, promote the production of body fluid admittedly take off, calm the nerves.Main pharmacological: 1 regulates the central nervous system, 2 promote the utilization of brain to energy matter, 3 improve cardiac function, 4 hypoglycemic activities, 5 enhancing body's immunological function, 6 improve the defensive ability/resistance ability to destructive stimulus, but the stress ability of enhancing body and adaptability, 7 antitumor actions, 8 antioxidations.
Radix Panacis Quinquefolii: have YIN nourishing and QI supplementing, the double effects that the mind calming and mentality promoting and clearing away heat and promoting production of body fluid, pathogenic fire reducing are relieved summer heat.Has human body immunity improving power, cancer is effectively resisted in the anticancer growth, can reduce blood coagulation, suppresses platelet aggregation, atherosclerosis and promote the erythrocyte growth, increase hematochrome, can blood sugar lowering, regulate insulin secretion, promote carbohydrate metabolism and lipid metabolism.
Stigma Croci: blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens.
The Pseudobulbus Bletillae (Rhizoma Bletillae): tonifying the lung, relieving cough and resolving phlegm, hemostasia and promoting granulation.
Radix Rhodiolae: QI invigorating lung heat clearing; Fructus Alpiniae Oxyphyllae is nourished heart; Hemostasis with astringents; Dissipating blood stasis for subsidence of swelling.Can strengthen the resistance of human body, have multiple physiologically actives such as cold resistance, resisting fatigue, defying age, resisting microwave radiation, have obvious enhancing body and support resistance and adaptability effect adverse environment.The central nervous system there are stronger inhibition and regulating action, resisting fatigue, anti-but oxygen, defying age, radioprotective, preventing tumor and antiinflammatory, detoxifcation, the effect of raising autoimmunity are preferably arranged, be the potential activator of human body self cell, nerve system of human body, blood circulation system, metabolic system, hormonal system etc. are had the good whole opsonic action.
Radix Notoginseng: hemostasis, dissipating blood stasis, detumescence, analgesic therapy.Have hemostasis, antithrombotic promotes hemopoietic, and antiinflammatory protects the liver, antitumor, effects such as analgesia.
Carapax Trionycis: nourishing YIN for suppressing the hyperactive YANG, the eliminating stagnation painful abdominal mass that disappears.
Herba Duchesneae Indicae: heat clearing away, removing heat from blood, detumescence, detoxifcation.Control calentura, infantile convulsion, laryngopharynx swelling and pain, dysentery, carbuncle, furuncle, snake bite and insect sting, burn are spitted blood in cough.
Deer spinal cord: enrich and benefit essence and blood, antiabortive hemostasis.Main pharmacological: 1. the lymphoblastic transformation of pair human body has facilitation, and effect is strong than the coliform lipopolysaccharide.2. to the influence of hemocyte: the erythrocyte around promoting in the blood, leukocyte, hematoblastic amount increases.3. promote the absorption and the intravital retention of calcium, make that calcium slightly increases in the blood, this calcareous carrying effect may be relevant with its contained glycine, and calcium can reduce capillary permeability, makes and oozes out minimizing, and antiinflammatory, detumescence and anti-allergic effects are arranged.
The beneficial effect that the present invention obtains is: Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Mori, the Rhizoma Anemarrhenae, Herba Artemisiae Annuae, Radix Rehmanniae, Rhizoma Polygonati Odorati, Flos Lonicerae, Semen Persicae, Radix Notoginseng etc. have promotes the production of body fluid, YIN nourishing, heat-clearing and toxic substances removing, blood circulation invigorating efficacies, Radix Rehmanniae Preparata, Radix Ginseng, Radix Angelicae Sinensis, Semen Ormosiae Hosiei, Radix Panacis Quinquefolii, Ganoderma, Fructus Jujubaes etc. have benefiting qi and nourishing blood, the harmonizing the liver and spleen effect, prescription integral body has direct killing effect to cancerous cell, simultaneously cancerous cell is transformed to normal cell, make QI and blood, lymphocyte normally moves, human body is normally moved, remove intravital tumor cell external, hematopoietic stem cell is got a promotion, strengthening vital QI to eliminate pathogenic factors, the effect that recovers body.
The specific embodiment
Below be concrete process for preparation of the present invention:
The first step adds the water of 1-3 times of weight with Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Rhizoma Phragmitis, Spica Prunellae according to preferred each component weight mixing, and little fire decocts above-mentioned medicine soup and the Rhizoma Dioscoreae mixing that will endure in 1-2 hour and soaks after 72 hours drying for standby.
Second step, the water that Fructus Psoraleae, Herba Cistanches, the Cortex Eucommiae, Herba Ecliptae, Fructus Mori is added 1-3 times of weight according to preferred each component weight mixing, little fire decocted 1-2 hour, the above-mentioned medicine soup endured and Radix Paeoniae Alba, Radix Paeoniae Rubra mixing are soaked 72 hours after, drying for standby.
The 3rd step added the water of 1-3 times of weight with the Rhizoma Anemarrhenae, Herba Artemisiae Annuae, Radix Rehmanniae, Radix Rehmanniae Preparata, Rhizoma Polygonati Odorati according to preferred each component weight mixing, and little fire decocted 1-2 hour, the above-mentioned medicine soup endured and Radix Angelicae Sinensis mixing are soaked 72 hours after, drying for standby.
The 4th step added the water of 1-3 times of weight with the Radix Astragali, Radix Glycyrrhizae, Flos Lonicerae, Semen Persicae, Poria according to preferred each component weight mixing, and little fire decocted 1-2 hour, the above-mentioned medicine soup endured and Rhizoma Atractylodis Macrocephalae mixing are soaked 72 hours after, drying for standby.
The 5th step added the water of 1-3 times of weight with Fructus Jujubae, Fructus Lycii, Semen Ormosiae Hosiei, Rhizoma Atractylodis according to preferred each component weight mixing, and little fire decocted 1-2 hour, the above-mentioned medicine soup endured and Ganoderma mixing are soaked 72 hours after, drying for standby.
The 6th step added the water of 1-3 times of weight with Radix Scrophulariae according to preferred component weight, and little fire decocted 1-2 hour, the above-mentioned medicine soup endured and Radix Et Rhizoma Rhei mixing are soaked 72 hours after, drying for standby.
The 7th step, Rhizoma Dioscoreae, Radix Paeoniae Alba, Radix Paeoniae Rubra, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Ganoderma, Radix Et Rhizoma Rhei, Cordyceps, Radix Ginseng, Radix Panacis Quinquefolii, Stigma Croci, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Rhodiolae, Radix Notoginseng, Carapax Trionycis, the above-mentioned 16 flavor Chinese medicines of Herba Duchesneae Indicae are made 200 order fine powders according to preferred each component weight, standby with 500 parts of deer spinal cord mixings then.
After said medicine prepared according to component, can take by fried according to a conventional method one-tenth decoction, also can manufacture medicine pill according to a conventional method, the Chinese medicine electuary is taken, can also daily dosage effective component extracting according to Chinese herbal medicine after, make capsule and quantitatively take on time.
Below be two routine model cases:
Model case 1: Liu XX, the man, 38 years old, in December, 2008 was gone to a doctor.
Chronic lymphocytic leukemia during prescription on individual diagnosis, the face pale asphyxia, liver spleen and lymph node begin enlargement, and not seeing has bleeding, the systemic sustained heating.Use the fried medicament of Chinese medicine of the present invention, method according to routine is fried, and one day twice, each potion of morning and evening, further consultation after taking medicine continuously 7, sb.'s illness took a favorable turn after conscious the taking medicine, and after taking medicine again 7, resembles disappearance to the positive disease of examination in hospital, recover certain work capacity after 1 year, physical recovery is normal after year a year and a half, does not have recurrence so far, can operate as normal.
Model case 2: king XX, the woman, 29 years old, went to a doctor in March, 2009
Aplastic anemia during prescription on individual diagnosis, the face pale asphyxia, not seeing has bleeding, the systemic sustained heating.Use the fried medicament of Chinese medicine of the present invention, method according to routine is fried, and one day twice, each potion of morning and evening, further consultation after taking medicine continuously 7, sb.'s illness took a favorable turn after conscious the taking medicine, and after taking medicine again 7, resembles disappearance to the positive disease of examination in hospital, recover certain work capacity after half a year, physical recovery is normal after 1 year, does not have recurrence so far, can operate as normal.
Use the present invention to treat leukaemic's 300 examples, cure rate reaches 95.8%, and effective percentage reaches 98.5%.
Facts have proved that the present invention treats leukemic Chinese prescription, belongs to pure Chinese medicinal preparation through a large amount of clinical treatments, little to the human body toxicity, side effect, have reliable, safety, notable therapeutic effect.
Claims (3)
1. treat leukemic Chinese medicine composition for one kind, it is characterized in that forming by the component of following proportioning by weight:
Fructus Ligustri Lucidi 60-150 part, Fructus Schisandrae Chinensis 20-80 part, Rhizoma Phragmitis 60-150 part, Spica Prunellae 20-80 part, Rhizoma Dioscoreae 20-80 part, Fructus Psoraleae 20-80 part, Herba Cistanches 60-150 part, Cortex Eucommiae 20-80 part, Herba Ecliptae 20-80 part, Fructus Mori 20-80 part, Radix Paeoniae Alba 20-80 part, Radix Paeoniae Rubra 20-80 part, Rhizoma Anemarrhenae 60-150 part, Herba Artemisiae Annuae 20-80 part, Radix Rehmanniae 20-80 part, Radix Rehmanniae Preparata 20-80 part, Rhizoma Polygonati Odorati 20-80 part, Radix Angelicae Sinensis 100-200 part, Radix Astragali 20-80 part, Radix Glycyrrhizae 5-35 part, Flos Lonicerae 20-80 part, Semen Persicae 20-80 part, Poria 20-80 part, Rhizoma Atractylodis Macrocephalae 20-80 part, Fructus Jujubae 20-80 part, Fructus Lycii 20-80 part, Semen Ormosiae Hosiei 20-80 part, Rhizoma Atractylodis 20-80 part, Ganoderma 100-200 part, Radix Scrophulariae 20-80 part, Radix Et Rhizoma Rhei 20-80 part, Cordyceps 9-20 part, Radix Ginseng 50-120 part, Radix Panacis Quinquefolii 60-150 part, Stigma Croci 9-20 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-80 part, Radix Rhodiolae 20-80 part, Radix Notoginseng 20-80 part, Carapax Trionycis 20-80 part, Herba Duchesneae Indicae 20-80 part, deer spinal cord 300-700 part.
2. the leukemic Chinese medicine composition of treatment according to claim 1 is characterized in that being made up of the component of following proportioning by weight:
Fructus Ligustri Lucidi 80-120 part, Fructus Schisandrae Chinensis 40-60 part, Rhizoma Phragmitis 80-120 part, Spica Prunellae 40-60 part, Rhizoma Dioscoreae 40-60 part, Fructus Psoraleae 40-60 part, Herba Cistanches 80-120 part, Cortex Eucommiae 40-60 part, Herba Ecliptae 40-60 part, Fructus Mori 40-60 part, Radix Paeoniae Alba 40-60 part, Radix Paeoniae Rubra 40-60 part, Rhizoma Anemarrhenae 80-120 part, Herba Artemisiae Annuae 40-60 part, Radix Rehmanniae 40-60 part, Radix Rehmanniae Preparata 40-60 part, Rhizoma Polygonati Odorati 40-60 part, Radix Angelicae Sinensis 130-170 part, Radix Astragali 40-60 part, Radix Glycyrrhizae 10-30 part, Flos Lonicerae 40-60 part, Semen Persicae 40-60 part, Poria 40-60 part, Rhizoma Atractylodis Macrocephalae 40-60 part, Fructus Jujubae 40-60 part, Fructus Lycii 40-60 part, Semen Ormosiae Hosiei 40-60 part, Rhizoma Atractylodis 40-60 part, Ganoderma 130-170 part, Radix Scrophulariae 40-60 part, Radix Et Rhizoma Rhei 40-60 part, Cordyceps 12-18 part, Radix Ginseng 60-100 part, Radix Panacis Quinquefolii 80-120 part, Stigma Croci 12-18 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-60 part, Radix Rhodiolae 40-60 part, Radix Notoginseng 40-60 part, Carapax Trionycis 40-60 part, Herba Duchesneae Indicae 40-60 part, deer spinal cord 400-600 part.
3. the leukemic Chinese medicine composition of treatment according to claim 2 is characterized in that being made up of the component of following proportioning by weight:
100 parts of Fructus Ligustri Lucidi, 50 parts of Fructus Schisandrae Chinensis, 100 parts of Rhizoma Phragmitiss, 50 parts of Spica Prunellaes, 50 parts of Rhizoma Dioscoreaes, 50 parts of Fructus Psoraleaes, 100 parts of Herba Cistanches, 50 parts of the Cortexs Eucommiae, 50 parts of Herba Ecliptaes, 50 parts of Fructus Mori, 50 parts of Radix Paeoniae Alba, 50 parts of Radix Paeoniae Rubras, 100 parts of the Rhizoma Anemarrhenaes, 50 parts of Herba Artemisiae Annuaes, 50 parts of Radix Rehmanniae, 50 parts of Radix Rehmanniae Preparata, 50 parts of Rhizoma Polygonati Odorati, 150 parts of Radix Angelicae Sinensis, 50 parts of the Radixs Astragali, 20 parts in Radix Glycyrrhizae, 50 parts of Flos Loniceraes, 50 parts in Semen Persicae, 50 parts in Poria, 50 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Fructus Jujubaes, 50 parts of Fructus Lycii, 50 parts of Semen Ormosiae Hosiei, 50 parts of Rhizoma Atractylodis, 150 parts of Ganodermas, 50 parts of Radix Scrophulariae, 50 parts of Radix Et Rhizoma Rhei, 15 parts of Cordyceps, 80 parts of Radix Ginsengs, 100 parts of Radix Panacis Quinquefoliis, 15 parts of Stigma Crocis, 50 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 50 parts of Radix Rhodiolaes, 50 parts of Radix Notoginseng, 50 parts of Carapax Trionycis, 50 parts of Herba Duchesneae Indicaes, 500 parts in deer spinal cord.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101459552A CN102210820A (en) | 2011-05-24 | 2011-05-24 | Chinese medicinal composition for treating leukemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101459552A CN102210820A (en) | 2011-05-24 | 2011-05-24 | Chinese medicinal composition for treating leukemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102210820A true CN102210820A (en) | 2011-10-12 |
Family
ID=44742504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101459552A Pending CN102210820A (en) | 2011-05-24 | 2011-05-24 | Chinese medicinal composition for treating leukemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102210820A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743579A (en) * | 2012-07-17 | 2012-10-24 | 李云启 | Qi tonifying and blood replenishing Chinese medicinal pills and preparation process thereof |
| CN103386071A (en) * | 2013-07-08 | 2013-11-13 | 周明千 | A Chinese herbal medicine combination for treating leukemia |
| CN103585471A (en) * | 2013-10-18 | 2014-02-19 | 张兆玺 | Traditional Chinese medicine composition for treating thrombocytopenia |
| CN104689087A (en) * | 2015-03-03 | 2015-06-10 | 山东凤鸣堂医药科技有限公司 | Traditional Chinese medicine composition for treating leukemia and preparation method thereof |
| CN105796733A (en) * | 2016-04-18 | 2016-07-27 | 张瑞武 | Traditional Chinese medicine composition for preventing cancers and preparation method thereof |
| CN106266202A (en) * | 2016-10-10 | 2017-01-04 | 南宁多灵生物科技有限公司 | One treats leukemic Chinese medicine composition |
| CN107550935A (en) * | 2017-09-11 | 2018-01-09 | 上海亚睿生物科技有限公司 | A kind of biological gel for treating joint disease and its application |
| CN107744591A (en) * | 2017-08-04 | 2018-03-02 | 武清堂 | A kind of anticancer, pure food formulation for cancer |
-
2011
- 2011-05-24 CN CN2011101459552A patent/CN102210820A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743579A (en) * | 2012-07-17 | 2012-10-24 | 李云启 | Qi tonifying and blood replenishing Chinese medicinal pills and preparation process thereof |
| CN102743579B (en) * | 2012-07-17 | 2013-09-11 | 李云启 | Qi tonifying and blood replenishing Chinese medicinal pills and preparation process thereof |
| CN103386071A (en) * | 2013-07-08 | 2013-11-13 | 周明千 | A Chinese herbal medicine combination for treating leukemia |
| CN103585471A (en) * | 2013-10-18 | 2014-02-19 | 张兆玺 | Traditional Chinese medicine composition for treating thrombocytopenia |
| CN103585471B (en) * | 2013-10-18 | 2015-06-10 | 张兆玺 | Traditional Chinese medicine composition for treating thrombocytopenia |
| CN104689087A (en) * | 2015-03-03 | 2015-06-10 | 山东凤鸣堂医药科技有限公司 | Traditional Chinese medicine composition for treating leukemia and preparation method thereof |
| CN105796733A (en) * | 2016-04-18 | 2016-07-27 | 张瑞武 | Traditional Chinese medicine composition for preventing cancers and preparation method thereof |
| CN106266202A (en) * | 2016-10-10 | 2017-01-04 | 南宁多灵生物科技有限公司 | One treats leukemic Chinese medicine composition |
| CN107744591A (en) * | 2017-08-04 | 2018-03-02 | 武清堂 | A kind of anticancer, pure food formulation for cancer |
| CN107550935A (en) * | 2017-09-11 | 2018-01-09 | 上海亚睿生物科技有限公司 | A kind of biological gel for treating joint disease and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN101485830B (en) | Pure Chinese medicine anti-aging health-care capsule | |
| CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN102210820A (en) | Chinese medicinal composition for treating leukemia | |
| CN101537120A (en) | Health care product for maintaining beauty and lengthening life | |
| CN103223131B (en) | Liver disease drug | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN101095768A (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
| CN103656048B (en) | Medicine being used for the treatment of mammitis of cow and preparation method thereof | |
| CN102727738B (en) | Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease, and preparation method thereof | |
| CN105902793A (en) | Traditional Chinese medicine for treatment of coronary heart disease | |
| CN103705733B (en) | One treats ARR Chinese medicinal capsule and preparation method thereof | |
| CN100394976C (en) | Chinese medicine for withdrawal of drug dependence | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
| CN101703660B (en) | Anti-aging medicament | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN105343675A (en) | Traditional Chinese medicine preparation for treating adiposis and preparation method thereof | |
| CN104173933A (en) | Traditional Chinese medicine composition for treating depressive disorder | |
| CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
| CN1242772C (en) | Chinese medicine for hemorrhoid | |
| CN101647965A (en) | Internal medicine for treating chronic nephritis | |
| CN101224295A (en) | Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof | |
| CN104645247A (en) | Traditional Chinese medicine preparation for treating hepatolenticular degeneration and preparation method of traditional Chinese medicine preparation | |
| CN105456447A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20111012 |